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Abstract
Background Visual analogue scales (VAS) are often used
to measure health-related quality of life (HRQoL). How-
ever, when such scales contain ambiguous anchors like
‘‘best imaginable health state,’’ they produce answers that
are difficult to interpret, as such anchors are interpreted
differently by respondents of different age. This phenom-
enon that people’s interpretation of subjective response
scales changes in response to changing circumstances is
known as scale recalibration. The current study attempts to
investigate whether scale recalibration in a patient sample
with cognitive limitations and proxies differs from the
general population.
Methods The participants in the current study were 151
pairs of community-dwelling patients with dementia and
their proxies. They were administered three VASs with
different upper anchors; (A) ‘‘best imaginable health
state,’’ (B) ‘‘best imaginable health state for someone your
age,’’ and (C) ‘‘best imaginable health state for a 25-year-
old.’’ From literature, we inferred a conceptual model for
the general population that predicts the ordinal relationship
of the VASs to be B C A C C. This rank order is tested by
repeated measure ANOVA’s in the aforementioned
populations.
Results VAS scores of patients with dementia were in
line with the conceptual model. Proxy VAS scores for
assessing patient HRQoL were not in line with the model:
A [ B [ C. In addition, proxy VAS scores for assessing
their own health were not in line with the model:
A [ B [ C.
Conclusion Patients with dementia use the VAS in a
similar way to the general population. Proxies assessing
either patients or themselves differ from the general
population.
Keywords Scale recalibration  Health-related quality of
life  Dementia  Visual analogue scale  Bias  Patient 
Proxy
Introduction
Health-related quality of life (HRQoL) is a patient-reported
outcome measure that is frequently assessed in health-care
evaluation research. There are two distinct ways to do this.
The first uses multidimensional instruments, grounded in
classical test theory that generates summary scores on
several domains. One such instrument is the MOS-Short
Form-36 [1]. The second uses instruments that provide an
overall HRQoL value in a single metric. Known as pref-
erence-based HRQoL classification systems, these are
based on specific valuation techniques. The resulting
preference-based HRQoL values (variously called utilities
or preference scores) are frequently used in cost-effec-
tiveness studies.
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One commonly applied HRQoL valuation technique is
the visual analogue scale (VAS). It has been used for
patients in numerous disease areas, but also for the general
public to value specific health states [2–5]. It is generally
accepted that its application is highly feasible and that it
shows moderate-to-good test–retest reliability. This tech-
nique is often used to assess patients’ HRQoL in longitu-
dinal studies [6–8]. However, it has some methodological
flaws; in particular, it is prone to end-aversion and context
bias. Furthermore, it is not embedded in a clear underlying
theoretical measurement framework [9–12]. In addition,
the anchors in these scales are potentially ambiguous, a
point on which this article expands [13].
Most VASs used to measure health states adopt ‘‘perfect
health’’ or, alternatively, ‘‘best imaginable health state’’ as
the upper anchor. However, such notions are ambiguous.
Individual respondents might understand the upper anchor
differently in light of their health status. For example, a
50-year-old to whom ‘‘perfect health’’ means as ‘‘perfect
health for someone my age’’ will probably give a different
answer than a 50-year-old respondent to whom it means
‘‘perfect health for someone without age-related problems
(for example 25 years old).’’ Since most studies use a VAS
with an ambiguous upper anchor their results might be
difficult to interpret, especially in groups with a wide range
in age. Indeed, respondents might disregard the upper
anchors entirely or misunderstand their intended meaning
when giving HRQoL ratings if they are not provided with a
well-defined frame of reference [14]. The phenomenon that
people’s interpretation of subjective response scales chan-
ges in response to changing circumstances is known as
scale recalibration [15–17].
Scale recalibration is one of three possible mechanisms
that allow for ‘‘response shift.’’ This concept refers to a
change in HRQoL outcomes attributable to changes in the
meaning of HRQoL, as understood or experienced by a
respondent. In addition to scale recalibration, a response
shift can reflect a change in the relative importance to a
respondent of the component domains of HRQoL (repri-
oritization) or a redefinition of one’s meaning of HRQoL
itself (reconceptualization) [15, 18].
Scale recalibration effects have been investigated by
Ubel et al. [13] in a representative sample of the elderly
randomly selected from the Health and Retirement Study
(HRS). Their study used VASs with three distinct upper
anchors: ‘‘perfect health,’’ ‘‘perfect health for someone
your age,’’ and ‘‘perfect health for a 20-year-old.’’ They
found that the three anchors were probably understood
differently, as they yielded different results. It is ques-
tionable whether these findings can be generalized to spe-
cific patient groups, however.
One of the objectives of the study on which the present
work is based was to investigate whether the findings
reported by Ubel et al. have generic properties. To that end,
this paper reports on an exercise to replicate their findings
in two specific populations. The first consists of patients
with cognitive limitations, that is, dementia. This popula-
tion is of particular interest because a valid and reliable
measurement of HRQoL is not as straightforward in
dementia as it is in many other disease areas. A decline in
intellectual capacity, semantic knowledge, and episodic
memory as well as deficits in judgment and insight, might
affect the validity of reported HRQoL values.
The second group consists of informal caregivers
(proxies) of the dementia patients. Proxy outcomes are
often used to assess the patient’s HRQoL when dementia
progresses to a stage in which patient assessment is no
longer meaningful. One problem with using proxies for this
purpose is that different cognitive processes might be at
work, and these could affect the reported values. For
example, proxies might prioritize domains differently than
the patients or conceptualize different domains of HRQoL.
Thus, when they rate patients, proxies may report different
values than those drawn patient self-assessment or proxy
self-assessment. In addition, proxies might ‘‘project’’ part
of their own HRQoL problems onto the patients’ HRQoL.
Of equal importance to the validity of HRQoL values of
patients with cognitive limitations is the answer to whether
scale recalibration occurs when assessing the HRQoL of
others.
The aim of the current exercise is to investigate scale
recalibration in dementia patients and proxies. It consti-
tutes a test of whether HRQoL values elicited on distinct




The current exercise draws its respondents from the
AD-Euro study (a cost-effectiveness study of post-diag-
nosis care in dementia) [19]. The AD-Euro study sought to
recruit 220 patient–proxy dyads and follow them for a
1-year period. Participants were recruited by a multidisci-
plinary memory clinic (MMC) physician directly after
diagnosis. The inclusion criteria were as follows: patients
with a newly diagnosed dementia fulfilling DSM-IV-TR
criteria and having a clinical dementia rating (CDR; 0–3)
score of 0.5–2: 0 for none, 0.5 for questionable/very mild, 1
for mild, 2 for moderate, and 3 for severe dementia [20,
21]. Patients were excluded if (1) their life expectancy was
less than 1 year, (2) they were living in a nursing home, (3)
they were already evaluated as being suitable for living in a
nursing home, (4) data collection was difficult (e.g., due to
980 Qual Life Res (2013) 22:979–986
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severe visual/hearing/language impairment, mood disorder,
or behavioral disturbances), (5) the patient’s general
practitioner did not agree to participate, (6) they were
already participating in another study, (7) they had visited
the MMC for a second opinion, (8) the travel distance
between the MMC and the patient’s residence was more
than 50 km, and (9) they had a definite indication for MMC
follow-up. In addition to the CDR, the Mini-Mental State
Examination (MMSE) was administered, although scores
on this instrument were not taken as an inclusion or
exclusion criterion [22]. For more details regarding the
AD-Euro study, the reader is referred to Meeuwsen et al.
[19].
Measurements for the current investigation were done at
6 months. Data were collected by trained interviewers who
administered the questionnaires (paper format) and the
response tasks at the patient’s home. Interviews were
planned in advance with both the patient and the proxy so
that data on both participants could be collected on the
same day and at the same location. The current exercise
includes only dyads of whom patients had completed at
least the VAS A (see below) rating at 6 months.
Measures
All HRQoL measures were particularizations of the EQ-5D
visual analogue scale (VAS A) [23]. VAS A is a 20 cm
vertical ‘‘thermometer’’ ranging from 0 to 100 where 0 is
defined as the ‘‘worst imaginable health state’’ and 100 is
defined as ‘‘best imaginable health state’’ (Fig. 1). In
addition to VAS A, two adapted VASs were administered
to both patients and proxies. These two VASs had different
upper anchors, but identical lower anchors. The first
alternative (VAS B) had a score of 100, defined as ‘‘the
best imaginable health state for someone your age’’ (for
proxies reporting on patients, a score of 100 was defined as
‘‘the best imaginable health state for someone the age of
the patient’’). The second alternative (VAS C) had a score
of 100, defined as ‘‘the best imaginable health state for a
25-year-old’’. Participants indicated their HRQoL first on
VAS A, then on VAS B, and finally on VAS C. There was
no between-participant randomization of the VASs.
Conceptual model
The rationale behind the model (provided below) was as
follows. When people assessed their HRQoL on VAS A, it
was uncertain whether or not age would be a factor in their
assessment. When people assessed their HRQoL on VAS
B, age should have been taken into account because it was
now salient. When people assessed their HRQoL on VAS
C, age should have been taken into account on a stable
anchor. In this conceptual model, HRQoL values were thus
composed of two factors: age and disease. Disease should
be regarded as any health-related condition apart from
aging that causes HRQoL to deteriorate, conditions such as
rheumatoid arthritis and depression or Alzheimer’s disease.
Both of these factors would influence the VAS values.
Three different cases are described below to illustrate the
potential scoring differences in this conceptual model
(Table 1).
An underlying assumption was that respondents would
assess their health in terms of decline. They would pre-
sumably start assessing their position on a scale from the
position of perfect health and then they would assess which
aspects are suboptimal. Furthermore, the assessments of
decline were assumed to consist of two factors, namely age
and disease. Thus, respondents who assessed their HRQoL
















































Fig. 1 Three VASs with different upper anchors (from left to right:
VAS A, VAS B, and VAS C)
Table 1 Three different cases to illustrate the influence of age on





VAS A VAS B VAS C
1 50 10 0 90–100 100 90
2 50 10 25 65–75 75 65
3 80 22 35 43–65 65 43
a A decline in health for age is calculated by 0.4 points for every year
above the age of 25 and is for illustrative purposes only
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age separately from that caused by disease. The values on
these factors were subsequently summed to capture an
overall decline in health; that number would then be sub-
tracted from the value for perfect health.
In addition, the three VASs were assumed to have
identical interval properties. This implies that a respondent
who identified a 20-point decline in HRQoL on a particular
VAS because of disease would subtract these 20 points on
each of the other VASs. Furthermore, health was assumed
to decline with age; HRQoL was assumed to have a posi-
tive correlation with health, disease a negative one, and
respondents were assumed capable of meaningfully
assessing their decline (disutility) with regard to age and
disease..
The abovementioned assumptions were rather strict;
however, relaxing some or all of these assumptions would
have made the conceptual model unnecessarily compli-
cated. As this paper should be regarded as a tentative
exercise to reproduce the results found by Ubel et al. in two
specific populations, we chose to formulate a simple
model, one that presents our thoughts in an easily inter-
pretable way.
Ordinal relationship
In mathematical terms, scores on the different VASs can be
expressed as follows:
YVAS A ¼ 100 DD  ða DAÞ þ e; ð1Þ
YVAS B ¼ 100 DD þ e; ð2Þ
YVAS C ¼ 100 DD  DA þ e: ð3Þ
where Y represents the score on the VAS, DD the disutility
of the health state caused by disease, DA the disutility of the
health state caused by age, and a a chance parameter that
corrects for the potential incorporation of DA as a factor.
This means that, on the individual level, a respondent can
either incorporate age-related disutility into the HRQoL
value or not, so a takes on a value of 1 or 0. At the
population level, a will represent the average of all
individuals and will thus be a number between 0 and 1.
The term e represents a random measurement error
component. The appendix provides a derivation for the
ordinal relationship
YVAS B  YVAS A  YVAS C: ð4Þ
Hypotheses and analyses
The ordinal relationship presented by the above conceptual
model was evaluated by testing the following two
hypotheses separately for three groups (patients self-
assessed, patients as assessed by proxies, and proxies self-
assessed).
1. YVAS B is significantly larger than YVAS A and YVAS C.
2. YVAS A is significantly smaller than YVAS B and
significantly larger than YVAS C.
Repeated measures ANOVAs with Bonferroni adjust-
ments for multiple comparisons were used on the scores of
the three VASs. Additionally, the agreement was examined
on VAS A, VAS B, and VAS C between patient–proxy
dyads (assessments on patients) by means of limits of
agreement (LoA) [24]. The difference scores (patient–
proxy) of each VAS were compared with the difference
scores for the other VASs by means of a repeated measures
ANOVA.
In order to investigate whether the type of proxy (spouse
vs. child) affected VAS ratings, the next step used a
MANOVA with YVAS A, YVAS B, and YVAS C as dependent
variables. The patient–proxy relationship was taken as a
fixed factor and patient age and proxy age were taken as
covariates. The limited sample size did not permit addi-
tional analyses of informative subgroups.
Results
Respondents
In total, 175 patient–proxy dyads were included in the AD-
Euro study at baseline. The current exercise used data
collected after 6 months. In total, 151 respondents were
included in the analyses (some patient–proxy dyads were
not, due to attrition). The mean age of the patients was 78
(SD 5.8) years and 60 % were female. Alzheimer’s disease
was the most prevalent diagnosis (62 %), followed by
mixed dementia (28 %), vascular dementia (5 %), and
other (4 %). Patient CDR scores were 0.5 (5.3 %), 1
(80.1 %), and 2 (14.6 %). The mean MMSE scores were 23
(SD 3.7). Patient–proxy relationships were defined as
partners (56 %), children (38 %), or other (6 %). Proxies
were 64 (SD 13.0) years of age and 70 % were female. The
respondent characteristics for this study and Ubel et al.’s
are given below for comparison (Table 2).
Scale recalibration
A statistically significant scale recalibration effect was seen
in ratings by patients, ratings of patients by proxies, and
proxies by themselves (Fig. 2). The scoring order on the
different VASs by patients was VAS B = VAS A [ VAS C.
This is in line with the rank order as predicted by the con-
ceptual model. Patient-by-proxy assessment produced results
that did not correspond to the model’s predictions. The
scoring order was VAS A [ VAS B [ VAS C. Proxy self-
assessment showed a pattern similar to patient-by-proxy
982 Qual Life Res (2013) 22:979–986
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assessment. Descriptive statistics of the ratings by patients,
proxies, and proxy-assessed patients on the three different
VASs are provided in Table 3.
Agreement
There was a wide range in agreement between patients and
proxies on the VASs (Fig. 3). However, the spread in
difference scores remains large on all three VASs, None-
theless, there was a significant increase in differences on
the agreement between the VASs (multivariate p \ 0.001).
Specifically, the difference between VAS A and VAS B
increased (x = 3.39, p = 0.026), the difference between
VAS A and VAS C increased (x = 14.52, p \ 0.001), and
the difference between VAS B and VAS C increased
(x = 11.12, p \ 0.001). The LoA of VAS A, VAS B,
and VAS C were -30.13–41.38, -32.16–50.20, and
-27.81–68.08, respectively.
Subgroup analyses
Ratings on VAS A, VAS B, and VAS C were not signifi-
cantly influenced by the age of the patient (p [ 0.1) or
proxy (p [ 0.1), nor the type of patient–proxy relationship
(spouse vs. child, p [ 0.1)
Discussion
This study has investigated whether potential scale recali-
bration by dementia patients and their informal caregivers
(proxies) differs from findings in the general population.
Three VASs with different upper anchors were used to
elicit HRQoL ratings.
A comparison between a VAS with the upper anchor
denoted as ‘‘best imaginable health state’’ (VASbest-health)
and another VAS defining it as ‘‘best imaginable health
state for someone your age’’ (VASyour-age) revealed similar
results for the patients. This might suggest that age-related
decline is not incorporated in patient self-rated HRQoL on
the VASbest-health. An alternative explanation is that
patients do not experience an age-related decline in health.
However, when the anchors were changed to perfect health
for a 25-year-old person (VAS25-years), they did assess their
HRQoL as lower, suggesting that patients do recognize that
their health has declined with age. Therefore, it seems
likely that patients do not incorporate age-related decline in
health in their HRQoL ratings on the VASbest-health. This
implies that the meaning of VASbest-health to patients does
not differ from its meaning to the general population (as
reported by Ubel et al.). That interpretation would remain
in line with the conceptual model presented in this article.
Despite the cognitive decline that the patient sample suf-
fered from, it appears that VASs are understood identically
Fig. 2 Difference scores in visual analogue scales in patients,
proxies, and patients assessed by proxies











Age; mean (SD) 78.4 (5.8) 64.5 (13.0) 68.1 (10.1) 68.0 (10.2) 68.9 (10.0)
Gender; % female 59.6 69.5 58.8 59.3 58.4
Activities of daily living;
% Reporting limitationsa,b
39.1 21.9 20.3 21.4 24.9
a In our study defined as scoring ‘‘some’’ or ‘‘severe’’ problems on the domains of mobility or self care on the EQ-5D
b In the study by Ubel et al. defined as indicating any problems on either walking, eating, bathing, dressing, getting in/out of bed, using the toilet,
or picking up a dime
Table 3 Mean VAS scores of patients, proxies, and patients assessed
by proxies on all 3 VASs
Type of VAS Valid n Mean SD
Patient VAS A 151 73.3 13.4
Patient VAS B 137 74.0 14.5
Patient VAS C 125 59.9 18.8
Patient-by-proxy VAS A 148 67.2 14.6
Patient-by-proxy VAS B 148 63.8 18.3
Patient-by-proxy VAS C 148 39.4 19.9
Proxy VAS A 149 77.8 13.2
Proxy VAS B 149 75.7 15.0
Proxy VAS C 147 59.5 17.6
Qual Life Res (2013) 22:979–986 983
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by the patients and the general population. Thus, there
seems to be no need for researchers and clinicians to
question the interpretation of results obtained by such
instruments.
Reviewing the patient-by-proxy assessments, a different
pattern emerges. Proxies give the patients’ health state a
higher rating on VASbest-health than on VASyour-age. Sur-
prisingly, this is not in line with the predictions of the
conceptual model. The only explanation that would fit the
model is that proxies consider age-related decline to be
negative (so proxies would have judged patients to have
shown improvement in their HRQoL as they aged), but this
seems highly unlikely. A more plausible explanation is that
the anchors mean different things to patients and proxies.
One mechanism that could drive such a discrepant attri-
bution is the decreasing scope for ambiguous responses in
the mind of the respondent. Consider the following hypo-
thetical example. It is possible that proxies understand
VASbest-health implicitly as ‘‘the best imaginable health state
for such a patient.’’ When they subsequently rate the health
state of the patient on VASyour-age, the proxies realize that,
compared to people of a patient’s age, the patients are
actually doing worse. Thus, they rate the patients lower on
VASyour-age. Consider another example: a proxy might
reason as follows when using VASbest-health to rate a
patient: ‘‘I know she has cognitive deficits, but she doesn’t
seem to mind.’’ When that same proxy subsequently rates
the same patient on VASyour-age, the reasoning could be
that: ‘‘She might not mind her cognitive deficits, but
compared to a normal person of her age her health has
declined.’’ Another possible explanation is that proxies
have less opportunity to adjust their own coping mecha-
nisms when shifting from VASbest-health to VASyour-age to
VAS25-years. Thus, as they rate the HRQoL of a patient,
they are partly rating their own provision of care. Such
cognitive processes might be one of the reasons there was
poor agreement between patients’ self-assessments and
proxies reporting on patients. In addition, they would fit the
trend of decreasing agreement from VASbest-health to
VASyour-age to VAS25-years.
Interestingly, when proxies assess their own HRQoL,
their scores are lower on VASyour-age than on to VASbest-
health. Apparently, they are judging their HRQoL as less
than normal for people of their own age. This observation
contradicts the conceptual model and it differs from what
Ubel et al. found, namely that people did not give different
scores for VASbest-health and VASyour-age. A possible
explanation for this discrepancy is that proxies see them-
selves as active caregivers, which creates more stress and a
greater burden than expected in a ‘‘normal’’ person their
age. These effects could decrease HRQoL among proxies,
depending on their coping style [25].
The finding that VASbest-health is rated higher than
VASyour-age is in contrast to what Ubel et al. found,
although this divergence might be explained by differences
in the research designs. In the study of Ubel et al., the
respondents only assessed their own HRQoL; they did not
rate the HRQoL of others. Furthermore, they used a
between-subject design, so that each individual received
only one version of the VAS.
A limitation of the work presented here is that a within-
subject design was used, without random ordering of the
VASs (because this explorative exercise was not the main
objective of the broader AD-Euro study). Therefore, it
cannot be ascertained whether the scale recalibration
effects are an artifact of order effects or whether they are
genuinely present and contrary to previous findings. Nev-
ertheless, when subjective HRQoL values are preferred and
proxies are used to assess these, researchers and clinicians
should be aware of the potential discrepancy between the
way patients and proxies understand the scale. Given the
research design underlying the current paper, it is impos-
sible to determine whether these discrepancies are sys-
tematic or not. Further research with longitudinal and
Fig. 3 Limits of agreements between patient–proxy dyads on VAS A, VAS B, and VAS C
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between-subject designs could be initiated to investigate
and overcome this limitation.
The work reported in the present paper has another
limitation. Although it is highly likely that the different
ratings were induced mainly by scale recalibration, other
causative factors cannot be ruled out. First of all, the for-
mulation of the anchors might have caused not only a
change in scale recalibration, but also some elements of
reconceptualization or reprioritization. For example, the
explicit description of age in VAS25-years might have trig-
gered recall of what was important to the respondent at that
age, thereby inducing a reconceptualization or reprioriti-
zation of HRQoL. A second observation that might explain
the difference in results between VASbest-health and
VASyour-age is that a substantial proportion of the respon-
dents gave little to no attention to the upper anchor of
VASbest-health, since this was the first VAS they were con-
fronted with [14]. However, this would not explain the
differences found between VASyour-age and VAS25-years, nor
those between VASbest-health and VAS25-years.
It should be noted that the assumption of equal interval
levels on the different VASs is strong. Relaxing this
assumption would demand additional transformations to
arrive at comparable HRQoL ratings. However, in the
current model, such transformations would involve unde-
fined parameters and therefore cannot be computed
directly. In theory, such transformations would allow for
comparable HRQoL estimates of all three VASs. Future
research should be conducted on potential additional
(chance) parameters that were not included in the con-
ceptual model presented here. That investigation could
elucidate whether the model can be extended in such a way
that the results of the present work would no longer be
violations of the conceptual model.
The current work was performed on a sample that
consisted mostly of patients with mild dementia. The
choice of this population might affect the generalizability
of the findings. For example, one could imagine that for
proxies who take care of patients at a more severe stage of
dementia, reconceptualization and reprioritization might
play a bigger role than reported in this article. These
reactions might then manifest themselves as different pat-
terns of VAS ratings than those presented here. Further-
more, the current paper cannot adequately distinguish
among the various cognitive processes that might be at
work when proxies evaluate patient HRQoL. It is possible
that assessing another person’s HRQoL in general leads to
the reported patterns, though these could also be caused by
the burden that the proxies have experienced. Future
research should address these issues. In addition, a repli-
cation of proxy assessment on different VASs with a
between-subject design is recommended. Such a study
would be necessary to investigate whether the results
reported here are replicable and representative of proxy
assessment but also to correct for potential ordering effects.
In conclusion, it is most likely that the use of VASbest-health
in patients with dementia will lead to scale recalibration in
patients with dementia. In addition, their understanding of
VASbest-health will be identical to VASyour-age. Researchers
and clinicians need to give these effects due consideration
when using VASbest-health in groups ranging widely in age.
Measurement by proxy does not comply with the conceptual
model presented here. Therefore, future research should be
done on HRQoL values assessed by proxies to identify
additional parameters. Their incorporation could be a step
toward explaining the deviations from the proposed model
but also the discrepancy between the expected results and the
patient self-assessed scores.
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Appendix
Here we will derive an ordinal scoring between YVAS A,
YVAS B and YVAS C. Starting with YVAS A and YVAS B. First,
we express Eq. (2) in terms of DD. This gives the equation
DD ¼ 100 YVAS B þ e:
Substituting 100  YVAS B þ e in YVAS A results in
YVAS A ¼ 100 100þ YVAS B  e aDAð Þ þ e ,
YVAS A ¼ YVAS B  aDAð Þ:
As a is defined as a non-negative parameter constrained
between 0 and 1 and e is a random term that disappears
from the equation it follows that
YVAS B  YVAS A:
Now we derive a scoring order for YVAS C.
DD ¼ 100 YVAS C  DA þ e:
Substituting 100 YVAS C  DA þ e in YVAS A results in
YVAS A ¼ 100 100þ YVAS C þ DA  e aDA þ e ,
Qual Life Res (2013) 22:979–986 985
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YVAS A ¼ YVAS C þ ð1 aÞDA ,
YVAS C ¼ YVAS A  ð1 aÞDA:
As a is defined as a non-negative parameter constrained
between 0 and 1 and e is a random term that disappears
from the equation it follows that
YVAS C  YVAS A:
We suppose a transitive relation so that if
YVAS B  YVAS A;
and
YVAS A  YVAS C;
then
YVAS B  YVAS C:
Now we arrive at the following VAS ordinal
relationship:
YVAS B  YVAS A  YVAS C: ð4Þ
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